Kou Junping, Yu Boyang, Xu Qiang
State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, PR China.
Vascul Pharmacol. 2005 Sep;43(3):157-63. doi: 10.1016/j.vph.2005.06.004.
The in-vivo inhibitory effects of the ethanol extract of Radix Ophiopogon japonicus (ROJ-ext) on venous thrombosis were studied in mouse and rat models and in-vitro endothelial cell-protective and anti-adhesive activities were observed in ECV304 cells injured by sodium dithionite and HL-60 adhesion to ECV304 cells injured by TNF-alpha. The in-vivo results showed that ROJ-ext significantly inhibited venous thrombosis induced by tight ligation of the inferior vena cava for 6 h in mice and for 24 h in rats by once oral administration at doses of 12.5 and 25 mg/kg. Meanwhile, ROJ-ext had no obvious effect on some coagulation parameters, which was different from warfarin, which remarkably prolonged activated partial thromboplastin time (APTT), thrombin time (TT) and prothrombin time (PT) in rats at the same time. Histological analysis under light microscope and scanning electron microscope (SEM) of inferior vena cava indicated that ROJ-ext could protect endothelial cells from anoxic injury and alleviate inflammatory changes in the vein wall. On the other hand, the in-vitro studies approved that ROJ-ext significantly enhanced viability of ECV304 cells injured by sodium dithionite at the concentrations of 0.1, 1.0 and 10 mug/ml when given before and after the anoxic induction. Meanwhile, ROJ-ext remarkably inhibited adhesion of HL-60 cells to ECV304 cells injured by rh TNF-alpha at above concentrations in a dose-dependent manner. The findings of this study showed that ethanol extract of Radix Ophiopogon japonicus (ROJ-ext) inhibited venous thrombosis, which linked with its endothelial cell-protective and anti-adhesive activities. This lends scientific support to the therapeutic use of the plant for thrombotic diseases.
在小鼠和大鼠模型中研究了麦冬乙醇提取物(ROJ-ext)对静脉血栓形成的体内抑制作用,并在连二亚硫酸钠损伤的ECV304细胞以及肿瘤坏死因子-α损伤的ECV304细胞上观察HL-60细胞黏附情况,以研究其体外内皮细胞保护和抗黏附活性。体内实验结果表明,以12.5和25mg/kg的剂量单次口服给药后,ROJ-ext能显著抑制小鼠下腔静脉结扎6小时和大鼠下腔静脉结扎24小时诱导的静脉血栓形成。同时,ROJ-ext对一些凝血参数没有明显影响,这与华法林不同,华法林会显著延长大鼠的活化部分凝血活酶时间(APTT)、凝血酶时间(TT)和凝血酶原时间(PT)。下腔静脉的光学显微镜和扫描电子显微镜(SEM)组织学分析表明,ROJ-ext可以保护内皮细胞免受缺氧损伤,并减轻静脉壁的炎症变化。另一方面,体外研究证实,在缺氧诱导前后给予ROJ-ext,其在0.1、1.0和10μg/ml浓度下能显著提高连二亚硫酸钠损伤的ECV304细胞的活力。同时,ROJ-ext在上述浓度下能以剂量依赖的方式显著抑制rh TNF-α损伤的ECV304细胞与HL-60细胞的黏附。本研究结果表明,麦冬乙醇提取物(ROJ-ext)抑制静脉血栓形成,这与其内皮细胞保护和抗黏附活性有关。这为该植物用于治疗血栓性疾病提供了科学依据。